Pharmaceuticals Global Industry Almanac 2016

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Scope

Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Reasons to buy

- What was the size of the global pharmaceuticals market by value in 2015?

- What will be the size of the global pharmaceuticals market in 2020?

- What factors are affecting the strength of competition in the global pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitors in the global pharmaceuticals market?

Companies mentioned

None

None

Table of Contents

EXECUTIVE SUMMARY

Market value

Market value forecast

Geography segmentation

Market share

Introduction

What is this report about?

Who is the target reader?

How to use ...

EXECUTIVE SUMMARY

Market value

Market value forecast

Geography segmentation

Market share

Introduction

What is this report about?

Who is the target reader?

How to use this report

Definitions

Global Pharmaceuticals

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Pharmaceuticals in Asia-Pacific

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Pharmaceuticals in Europe

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Pharmaceuticals in France

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in Germany

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in Australia

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in Brazil

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in Canada

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in China

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in India

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in Indonesia

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in Italy

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in Japan

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in Mexico

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in The Netherlands

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in North America

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Pharmaceuticals in Russia

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in Scandinavia

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Pharmaceuticals in Singapore

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in South Africa

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in South Korea

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in Spain

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in Turkey

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in The United Kingdom

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Pharmaceuticals in The United States

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Company Profiles

Leading companies

Appendix

Methodology

About MarketLine

List of Tables

Table 1: Global pharmaceuticals market value: $ billion, 2011–15

Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2015

Table 3: Global pharmaceuticals market share: ...

Table 1: Global pharmaceuticals market value: $ billion, 2011–15

Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2015

Table 3: Global pharmaceuticals market share: % share, by value, 2015

Table 4: Global pharmaceuticals market value forecast: $ billion, 2015–20

Table 5: Asia-Pacific pharmaceuticals market value: $ billion, 2011–15

Table 6: Asia–Pacific pharmaceuticals market geography segmentation: $ billion, 2015

Table 7: Asia-Pacific pharmaceuticals market share: % share, by value, 2015

Table 8: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2015–20

Table 9: Europe pharmaceuticals market value: $ billion, 2011–15

Table 10: Europe pharmaceuticals market geography segmentation: $ billion, 2015

Table 11: Europe pharmaceuticals market share: % share, by value, 2015

Table 12: Europe pharmaceuticals market value forecast: $ billion, 2015–20

Table 13: France pharmaceuticals market value: $ billion, 2011–15

Table 14: France pharmaceuticals market geography segmentation: $ billion, 2015

Table 15: France pharmaceuticals market share: % share, by value, 2015

Table 16: France pharmaceuticals market value forecast: $ billion, 2015–20

Table 17: France size of population (million), 2011–15

Table 18: France gdp (constant 2005 prices, $ billion), 2011–15

Table 19: France gdp (current prices, $ billion), 2011–15

Table 20: France inflation, 2011–15

Table 21: France consumer price index (absolute), 2011–15

Table 22: France exchange rate, 2011–15

Table 23: Germany pharmaceuticals market value: $ billion, 2011–15

Table 24: Germany pharmaceuticals market geography segmentation: $ billion, 2015

Table 25: Germany pharmaceuticals market share: % share, by value, 2015

Table 26: Germany pharmaceuticals market value forecast: $ billion, 2015–20

Table 27: Germany size of population (million), 2011–15

Table 28: Germany gdp (constant 2005 prices, $ billion), 2011–15

Table 29: Germany gdp (current prices, $ billion), 2011–15

Table 30: Germany inflation, 2011–15

Table 31: Germany consumer price index (absolute), 2011–15

Table 32: Germany exchange rate, 2011–15

Table 33: Australia pharmaceuticals market value: $ billion, 2011–15

Table 34: Australia pharmaceuticals market geography segmentation: $ billion, 2015

Table 35: Australia pharmaceuticals market share: % share, by value, 2015

Table 36: Australia pharmaceuticals market value forecast: $ billion, 2015–20

Table 37: Australia size of population (million), 2011–15

Table 38: Australia gdp (constant 2005 prices, $ billion), 2011–15

Table 39: Australia gdp (current prices, $ billion), 2011–15

Table 40: Australia inflation, 2011–15

Table 41: Australia consumer price index (absolute), 2011–15

Table 42: Australia exchange rate, 2011–15

Table 43: Brazil pharmaceuticals market value: $ billion, 2011–15

Table 44: Brazil pharmaceuticals market geography segmentation: $ billion, 2015

Table 45: Brazil pharmaceuticals market share: % share, by value, 2015

Table 46: Brazil pharmaceuticals market value forecast: $ billion, 2015–20

Table 47: Brazil size of population (million), 2011–15

Table 48: Brazil gdp (constant 2005 prices, $ billion), 2011–15

Table 49: Brazil gdp (current prices, $ billion), 2011–15

Table 50: Brazil inflation, 2011–15

Table 51: Brazil consumer price index (absolute), 2011–15

Table 52: Brazil exchange rate, 2011–15

Table 53: Canada pharmaceuticals market value: $ billion, 2011–15

Table 54: Canada pharmaceuticals market geography segmentation: $ billion, 2015

Table 55: Canada pharmaceuticals market share: % share, by value, 2015

Table 56: Canada pharmaceuticals market value forecast: $ billion, 2015–20

Table 57: Canada size of population (million), 2011–15

Table 58: Canada gdp (constant 2005 prices, $ billion), 2011–15

Table 59: Canada gdp (current prices, $ billion), 2011–15

Table 60: Canada inflation, 2011–15

Table 61: Canada consumer price index (absolute), 2011–15

Table 62: Canada exchange rate, 2011–15

Table 63: China pharmaceuticals market value: $ billion, 2011–15

Table 64: China pharmaceuticals market geography segmentation: $ billion, 2015

Table 65: China pharmaceuticals market share: % share, by value, 2015

Table 66: China pharmaceuticals market value forecast: $ billion, 2015–20

Table 67: China size of population (million), 2011–15

Table 68: China gdp (constant 2005 prices, $ billion), 2011–15

Table 69: China gdp (current prices, $ billion), 2011–15

Table 70: China inflation, 2011–15

Table 71: China consumer price index (absolute), 2011–15

Table 72: China exchange rate, 2011–15

Table 73: India pharmaceuticals market value: $ billion, 2011–15

Table 74: India pharmaceuticals market geography segmentation: $ billion, 2015

Table 75: India pharmaceuticals market share: % share, by value, 2015

Table 76: India pharmaceuticals market value forecast: $ billion, 2015–20

Table 77: India size of population (million), 2011–15

Table 78: India gdp (constant 2005 prices, $ billion), 2011–15

Table 79: India gdp (current prices, $ billion), 2011–15

Table 80: India inflation, 2011–15

Table 81: India consumer price index (absolute), 2011–15

Table 82: India exchange rate, 2011–15

Table 83: Indonesia pharmaceuticals market value: $ billion, 2011–15

Table 84: Indonesia pharmaceuticals market geography segmentation: $ billion, 2015

Table 85: Indonesia pharmaceuticals market share: % share, by value, 2015

Table 86: Indonesia pharmaceuticals market value forecast: $ billion, 2015–20

Table 87: Indonesia size of population (million), 2011–15

Table 88: Indonesia gdp (constant 2005 prices, $ billion), 2011–15

Table 89: Indonesia gdp (current prices, $ billion), 2011–15

Table 90: Indonesia inflation, 2011–15

Table 91: Indonesia consumer price index (absolute), 2011–15

Table 92: Indonesia exchange rate, 2011–15

Table 93: Italy pharmaceuticals market value: $ billion, 2011–15

Table 94: Italy pharmaceuticals market geography segmentation: $ billion, 2015

Table 95: Italy pharmaceuticals market share: % share, by value, 2015

Table 96: Italy pharmaceuticals market value forecast: $ billion, 2015–20

Table 97: Italy size of population (million), 2011–15

Table 98: Italy gdp (constant 2005 prices, $ billion), 2011–15

Table 99: Italy gdp (current prices, $ billion), 2011–15

Table 100: Italy inflation, 2011–15

Table 101: Italy consumer price index (absolute), 2011–15

Table 102: Italy exchange rate, 2011–15

Table 103: Japan pharmaceuticals market value: $ billion, 2011–15

Table 104: Japan pharmaceuticals market geography segmentation: $ billion, 2015

Table 105: Japan pharmaceuticals market share: % share, by value, 2015

Table 106: Japan pharmaceuticals market value forecast: $ billion, 2015–20

Table 107: Japan size of population (million), 2011–15

Table 108: Japan gdp (constant 2005 prices, $ billion), 2011–15

Table 109: Japan gdp (current prices, $ billion), 2011–15

Table 110: Japan inflation, 2011–15

Table 111: Japan consumer price index (absolute), 2011–15

Table 112: Japan exchange rate, 2011–15

Table 113: Mexico pharmaceuticals market value: $ billion, 2011–15

Table 114: Mexico pharmaceuticals market geography segmentation: $ billion, 2015

Table 115: Mexico pharmaceuticals market share: % share, by value, 2015

Table 116: Mexico pharmaceuticals market value forecast: $ billion, 2015–20

Table 117: Mexico size of population (million), 2011–15

Table 118: Mexico gdp (constant 2005 prices, $ billion), 2011–15

Table 119: Mexico gdp (current prices, $ billion), 2011–15

Table 120: Mexico inflation, 2011–15

Table 121: Mexico consumer price index (absolute), 2011–15

Table 122: Mexico exchange rate, 2011–15

Table 123: Netherlands pharmaceuticals market value: $ billion, 2011–15

Table 124: Netherlands pharmaceuticals market geography segmentation: $ billion, 2015

Table 125: Netherlands pharmaceuticals market share: % share, by value, 2015

Table 126: Netherlands pharmaceuticals market value forecast: $ billion, 2015–20

Table 127: Netherlands size of population (million), 2011–15

Table 128: Netherlands gdp (constant 2005 prices, $ billion), 2011–15

Table 129: Netherlands gdp (current prices, $ billion), 2011–15

Table 130: Netherlands inflation, 2011–15

Table 131: Netherlands consumer price index (absolute), 2011–15

Table 132: Netherlands exchange rate, 2011–15

Table 133: North America pharmaceuticals market value: $ billion, 2011–15

Table 134: North America pharmaceuticals market geography segmentation: $ billion, 2015

Table 135: North America pharmaceuticals market share: % share, by value, 2015

Table 136: North America pharmaceuticals market value forecast: $ billion, 2015–20

Table 137: Russia pharmaceuticals market value: $ billion, 2011–15

Table 138: Russia pharmaceuticals market geography segmentation: $ billion, 2015

Table 139: Russia pharmaceuticals market share: % share, by value, 2015

Table 140: Russia pharmaceuticals market value forecast: $ billion, 2015–20

Table 141: Russia size of population (million), 2011–15

Table 142: Russia gdp (constant 2005 prices, $ billion), 2011–15

Table 143: Russia gdp (current prices, $ billion), 2011–15

Table 144: Russia inflation, 2011–15

Table 145: Russia consumer price index (absolute), 2011–15

Table 146: Russia exchange rate, 2011–15

Table 147: Scandinavia pharmaceuticals market value: $ billion, 2011–15

Table 148: Scandinavia pharmaceuticals market geography segmentation: $ billion, 2015

Table 149: Scandinavia pharmaceuticals market share: % share, by value, 2015

Table 150: Scandinavia pharmaceuticals market value forecast: $ billion, 2015–20

Table 151: Singapore pharmaceuticals market value: $ billion, 2011–15

Table 152: Singapore pharmaceuticals market geography segmentation: $ billion, 2015

Table 153: Singapore pharmaceuticals market share: % share, by value, 2015

Table 154: Singapore pharmaceuticals market value forecast: $ billion, 2015–20

Table 155: Singapore size of population (million), 2011–15

Table 156: Singapore gdp (constant 2005 prices, $ billion), 2011–15

Table 157: Singapore gdp (current prices, $ billion), 2011–15

Table 158: Singapore inflation, 2011–15

Table 159: Singapore consumer price index (absolute), 2011–15

Table 160: Singapore exchange rate, 2011–15

Table 161: South Africa pharmaceuticals market value: $ billion, 2011–15

Table 162: South Africa pharmaceuticals market geography segmentation: $ billion, 2015

Table 163: South Africa pharmaceuticals market share: % share, by value, 2015

Table 164: South Africa pharmaceuticals market value forecast: $ billion, 2015–20

Table 165: South Africa size of population (million), 2011–15

Table 166: South Africa gdp (constant 2005 prices, $ billion), 2011–15

Table 167: South Africa gdp (current prices, $ billion), 2011–15

Table 168: South Africa inflation, 2011–15

Table 169: South Africa consumer price index (absolute), 2011–15

Table 170: South Africa exchange rate, 2011–15

Table 171: South Korea pharmaceuticals market value: $ billion, 2011–15

Table 172: South Korea pharmaceuticals market geography segmentation: $ billion, 2015

Table 173: South Korea pharmaceuticals market share: % share, by value, 2015

Table 174: South Korea pharmaceuticals market value forecast: $ billion, 2015–20

Table 175: South Korea size of population (million), 2011–15

Table 176: South Korea gdp (constant 2005 prices, $ billion), 2011–15

Table 177: South Korea gdp (current prices, $ billion), 2011–15

Table 178: South Korea inflation, 2011–15

Table 179: South Korea consumer price index (absolute), 2011–15

Table 180: South Korea exchange rate, 2011–15

Table 181: Spain pharmaceuticals market value: $ billion, 2011–15

Table 182: Spain pharmaceuticals market geography segmentation: $ billion, 2015

Table 183: Spain pharmaceuticals market share: % share, by value, 2015

Table 184: Spain pharmaceuticals market value forecast: $ billion, 2015–20

Table 185: Spain size of population (million), 2011–15

Table 186: Spain gdp (constant 2005 prices, $ billion), 2011–15

Table 187: Spain gdp (current prices, $ billion), 2011–15

Table 188: Spain inflation, 2011–15

Table 189: Spain consumer price index (absolute), 2011–15

Table 190: Spain exchange rate, 2011–15

Table 191: Turkey pharmaceuticals market value: $ billion, 2011–15

Table 192: Turkey pharmaceuticals market geography segmentation: $ billion, 2015

Table 193: Turkey pharmaceuticals market share: % share, by value, 2015

Table 194: Turkey pharmaceuticals market value forecast: $ billion, 2015–20

Table 195: Turkey size of population (million), 2011–15

Table 196: Turkey gdp (constant 2005 prices, $ billion), 2011–15

Table 197: Turkey gdp (current prices, $ billion), 2011–15

Table 198: Turkey inflation, 2011–15

Table 199: Turkey consumer price index (absolute), 2011–15

Table 200: Turkey exchange rate, 2011–15

Table 201: United Kingdom pharmaceuticals market value: $ billion, 2011–15

Table 202: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2015

Table 203: United Kingdom pharmaceuticals market share: % share, by value, 2015

Table 204: United Kingdom pharmaceuticals market value forecast: $ billion, 2015–20

Table 205: United Kingdom size of population (million), 2011–15

Table 206: United Kingdom gdp (constant 2005 prices, $ billion), 2011–15

Table 207: United Kingdom gdp (current prices, $ billion), 2011–15

Table 208: United Kingdom inflation, 2011–15

Table 209: United Kingdom consumer price index (absolute), 2011–15

Table 210: United Kingdom exchange rate, 2011–15

Table 211: United States pharmaceuticals market value: $ billion, 2011–15

Table 212: United States pharmaceuticals market geography segmentation: $ billion, 2015

Table 213: United States pharmaceuticals market share: % share, by value, 2015

Table 214: United States pharmaceuticals market value forecast: $ billion, 2015–20

Table 215: United States size of population (million), 2011–15

Table 216: United States gdp (constant 2005 prices, $ billion), 2011–15

Table 217: United States gdp (current prices, $ billion), 2011–15

Table 218: United States inflation, 2011–15

Table 219: United States consumer price index (absolute), 2011–15

Table 220: United States exchange rate, 2011–15

Table 221: Johnson & Johnson: key facts

Table 222: Johnson & Johnson: key financials ($)

Table 223: Johnson & Johnson: key financial ratios

Table 224: Novartis AG: key facts

Table 225: Novartis AG: key financials ($)

Table 226: Novartis AG: key financial ratios

Table 227: Pfizer Inc.: key facts

Table 228: Pfizer Inc.: key financials ($)

Table 229: Pfizer Inc.: key financial ratios

Table 230: F. Hoffmann-La Roche Ltd: key facts

Table 231: F. Hoffmann-La Roche Ltd: key financials ($)

Table 232: F. Hoffmann-La Roche Ltd: key financials (CHF)

Table 233: F. Hoffmann-La Roche Ltd: key financial ratios

Table 234: Daiichi Sankyo Co., Ltd.: key facts

Table 235: Daiichi Sankyo Co., Ltd.: key financials ($)

Table 236: Daiichi Sankyo Co., Ltd.: key financials (¥)

Table 237: Daiichi Sankyo Co., Ltd.: key financial ratios

Table 238: Dr. Reddy's Laboratories Limited: key facts

Table 239: Dr. Reddy's Laboratories Limited: key financials ($)

Table 240: Dr. Reddy's Laboratories Limited: key financials (Rs.)

Table 241: Dr. Reddy's Laboratories Limited: key financial ratios

Table 242: Shanghai Pharmaceuticals Holding Co Ltd: key facts

Table 243: Yangtze River Pharmaceutical Group: key facts

Table 244: Sanofi SA: key facts

Table 245: Sanofi SA: key financials ($)

Table 246: Sanofi SA: key financials (€)

Table 247: Sanofi SA: key financial ratios

Table 248: AstraZeneca PLC: key facts

Table 249: AstraZeneca PLC: key financials ($)

Table 250: AstraZeneca PLC: key financial ratios

Table 251: Laboratoires Pierre Fabre SA: key facts

Table 252: Les Laboratoires Servier: key facts

Table 253: Bayer AG: key facts

Table 254: Bayer AG: key financials ($)

Table 255: Bayer AG: key financials (€)

Table 256: Bayer AG: key financial ratios

Table 257: Boehringer Ingelheim GmbH: key facts

Table 258: Boehringer Ingelheim GmbH: key financials ($)

Table 259: Boehringer Ingelheim GmbH: key financials (€)

Table 260: Boehringer Ingelheim GmbH: key financial ratios

Table 261: GlaxoSmithKline Plc: key facts

Table 262: GlaxoSmithKline Plc: key financials ($)

Table 263: GlaxoSmithKline Plc: key financials (£)

Table 264: GlaxoSmithKline Plc: key financial ratios

Table 265: Aspen Pharmacare Holdings Ltd: key facts

Table 266: Aspen Pharmacare Holdings Ltd: key financials ($)

Table 267: Aspen Pharmacare Holdings Ltd: key financials (ZAR)

Table 268: Aspen Pharmacare Holdings Ltd: key financial ratios

Table 269: Aché Laboratórios Farmacêuticos S.A.: key facts

Table 270: EMS Sigma Pharma: key facts

Table 271: Apotex, Inc.: key facts

Table 272: Merck & Co., Inc.: key facts

Table 273: Merck & Co., Inc.: key financials ($)

Table 274: Merck & Co., Inc.: key financial ratios

Table 275: Guangzhou Pharmaceutical Holdings Limited: key facts

Table 276: Yunnan Baiyao Group Co., Ltd.: key facts

Table 277: Yunnan Baiyao Group Co., Ltd.: key financials ($)

Table 278: Yunnan Baiyao Group Co., Ltd.: key financials (CNY)

Table 279: Yunnan Baiyao Group Co., Ltd.: key financial ratios

Table 280: Aurobindo Pharma Limited: key facts

Table 281: Aurobindo Pharma Limited: key financials ($)

Table 282: Aurobindo Pharma Limited: key financials (Rs.)

Table 283: Aurobindo Pharma Limited: key financial ratios

Table 284: Lupin Limited: key facts

Table 285: Lupin Limited: key financials ($)

Table 286: Lupin Limited: key financials (Rs.)

Table 287: Lupin Limited: key financial ratios

Table 288: Sun Pharmaceutical Industries Ltd.: key facts

Table 289: Sun Pharmaceutical Industries Ltd.: key financials ($)

Table 290: Sun Pharmaceutical Industries Ltd.: key financials (Rs.)

Table 291: Sun Pharmaceutical Industries Ltd.: key financial ratios

Table 292: PT Kalbe Farma Tbk: key facts

Table 293: PT Kalbe Farma Tbk: key financials ($)

Table 294: PT Kalbe Farma Tbk: key financials (Rs.)

Table 295: PT Kalbe Farma Tbk: key financial ratios

Table 296: Chiesi Farmaceutici S.p.A.: key facts

Table 297: The Menarini Group: key facts

Table 298: Recordati S.p.A.: key facts

Table 299: Astellas Pharma GmbH: key facts

Table 300: Astellas Pharma GmbH: key financials ($)

Table 301: Astellas Pharma GmbH: key financials (¥)

Table 302: Astellas Pharma GmbH: key financial ratios

Table 303: Takeda Pharmaceutical Company Limited: key facts

Table 304: Takeda Pharmaceutical Company Limited: key financials ($)

Table 305: Takeda Pharmaceutical Company Limited: key financials (¥)

Table 306: Takeda Pharmaceutical Company Limited: key financial ratios

Table 307: Adcock Ingram Holdings Limited: key facts

Table 308: Adcock Ingram Holdings Limited: key financials ($)

Table 309: Adcock Ingram Holdings Limited: key financials (ZAR)

Table 310: Adcock Ingram Holdings Limited: key financial ratios

Table 311: CKD Bio Corporation: key facts

Table 312: Daewoong Pharmaceutical Co., Ltd.: key facts

Table 313: Daewoong Pharmaceutical Co., Ltd.: key financials ($)

Table 314: Daewoong Pharmaceutical Co., Ltd.: key financials (KRW)

Table 315: Daewoong Pharmaceutical Co., Ltd.: key financial ratios

Table 316: Hanmi Science Co., Ltd.: key facts

Table 317: Almirall S.A.: key facts

Table 318: Almirall S.A.: key financials ($)

Table 319: Almirall S.A.: key financials (€)

Table 320: Almirall S.A.: key financial ratios

Table 321: Abdi İbrahim: key facts

List of Figures

Figure 1: Global pharmaceuticals market value: $ billion, 2011–15

Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 3: Global pharmaceuticals ...

Figure 1: Global pharmaceuticals market value: $ billion, 2011–15

Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 3: Global pharmaceuticals market share: % share, by value, 2015

Figure 4: Global pharmaceuticals market value forecast: $ billion, 2015–20

Figure 5: Forces driving competition in the global pharmaceuticals market, 2015

Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2015

Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2015

Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2015

Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2015

Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2015

Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2011–15

Figure 12: Asia–Pacific pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2015

Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2015–20

Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2015

Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2015

Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2015

Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2015

Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2015

Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2015

Figure 21: Europe pharmaceuticals market value: $ billion, 2011–15

Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 23: Europe pharmaceuticals market share: % share, by value, 2015

Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2015–20

Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2015

Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2015

Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2015

Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2015

Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2015

Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2015

Figure 31: France pharmaceuticals market value: $ billion, 2011–15

Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 33: France pharmaceuticals market share: % share, by value, 2015

Figure 34: France pharmaceuticals market value forecast: $ billion, 2015–20

Figure 35: Forces driving competition in the pharmaceuticals market in France, 2015

Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2015

Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2015

Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2015

Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2015

Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2015

Figure 41: Germany pharmaceuticals market value: $ billion, 2011–15

Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 43: Germany pharmaceuticals market share: % share, by value, 2015

Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2015–20

Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2015

Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2015

Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2015

Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2015

Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2015

Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2015

Figure 51: Australia pharmaceuticals market value: $ billion, 2011–15

Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 53: Australia pharmaceuticals market share: % share, by value, 2015

Figure 54: Australia pharmaceuticals market value forecast: $ billion, 2015–20

Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2015

Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2015

Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2015

Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2015

Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2015

Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2015

Figure 61: Brazil pharmaceuticals market value: $ billion, 2011–15

Figure 62: Brazil pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 63: Brazil pharmaceuticals market share: % share, by value, 2015

Figure 64: Brazil pharmaceuticals market value forecast: $ billion, 2015–20

Figure 65: Forces driving competition in the pharmaceuticals market in Brazil, 2015

Figure 66: Drivers of buyer power in the pharmaceuticals market in Brazil, 2015

Figure 67: Drivers of supplier power in the pharmaceuticals market in Brazil, 2015

Figure 68: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2015

Figure 69: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2015

Figure 70: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2015

Figure 71: Canada pharmaceuticals market value: $ billion, 2011–15

Figure 72: Canada pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 73: Canada pharmaceuticals market share: % share, by value, 2015

Figure 74: Canada pharmaceuticals market value forecast: $ billion, 2015–20

Figure 75: Forces driving competition in the pharmaceuticals market in Canada, 2015

Figure 76: Drivers of buyer power in the pharmaceuticals market in Canada, 2015

Figure 77: Drivers of supplier power in the pharmaceuticals market in Canada, 2015

Figure 78: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2015

Figure 79: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2015

Figure 80: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2015

Figure 81: China pharmaceuticals market value: $ billion, 2011–15

Figure 82: China pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 83: China pharmaceuticals market share: % share, by value, 2015

Figure 84: China pharmaceuticals market value forecast: $ billion, 2015–20

Figure 85: Forces driving competition in the pharmaceuticals market in China, 2015

Figure 86: Drivers of buyer power in the pharmaceuticals market in China, 2015

Figure 87: Drivers of supplier power in the pharmaceuticals market in China, 2015

Figure 88: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2015

Figure 89: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2015

Figure 90: Drivers of degree of rivalry in the pharmaceuticals market in China, 2015

Figure 91: India pharmaceuticals market value: $ billion, 2011–15

Figure 92: India pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 93: India pharmaceuticals market share: % share, by value, 2015

Figure 94: India pharmaceuticals market value forecast: $ billion, 2015–20

Figure 95: Forces driving competition in the pharmaceuticals market in India, 2015

Figure 96: Drivers of buyer power in the pharmaceuticals market in India, 2015

Figure 97: Drivers of supplier power in the pharmaceuticals market in India, 2015

Figure 98: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2015

Figure 99: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2015

Figure 100: Drivers of degree of rivalry in the pharmaceuticals market in India, 2015

Figure 101: Indonesia pharmaceuticals market value: $ billion, 2011–15

Figure 102: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 103: Indonesia pharmaceuticals market share: % share, by value, 2015

Figure 104: Indonesia pharmaceuticals market value forecast: $ billion, 2015–20

Figure 105: Forces driving competition in the pharmaceuticals market in Indonesia, 2015

Figure 106: Drivers of buyer power in the pharmaceuticals market in Indonesia, 2015

Figure 107: Drivers of supplier power in the pharmaceuticals market in Indonesia, 2015

Figure 108: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Indonesia, 2015

Figure 109: Factors influencing the threat of substitutes in the pharmaceuticals market in Indonesia, 2015

Figure 110: Drivers of degree of rivalry in the pharmaceuticals market in Indonesia, 2015

Figure 111: Italy pharmaceuticals market value: $ billion, 2011–15

Figure 112: Italy pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 113: Italy pharmaceuticals market share: % share, by value, 2015

Figure 114: Italy pharmaceuticals market value forecast: $ billion, 2015–20

Figure 115: Forces driving competition in the pharmaceuticals market in Italy, 2015

Figure 116: Drivers of buyer power in the pharmaceuticals market in Italy, 2015

Figure 117: Drivers of supplier power in the pharmaceuticals market in Italy, 2015

Figure 118: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2015

Figure 119: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2015

Figure 120: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2015

Figure 121: Japan pharmaceuticals market value: $ billion, 2011–15

Figure 122: Japan pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 123: Japan pharmaceuticals market share: % share, by value, 2015

Figure 124: Japan pharmaceuticals market value forecast: $ billion, 2015–20

Figure 125: Forces driving competition in the pharmaceuticals market in Japan, 2015

Figure 126: Drivers of buyer power in the pharmaceuticals market in Japan, 2015

Figure 127: Drivers of supplier power in the pharmaceuticals market in Japan, 2015

Figure 128: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2015

Figure 129: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2015

Figure 130: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2015

Figure 131: Mexico pharmaceuticals market value: $ billion, 2011–15

Figure 132: Mexico pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 133: Mexico pharmaceuticals market share: % share, by value, 2015

Figure 134: Mexico pharmaceuticals market value forecast: $ billion, 2015–20

Figure 135: Forces driving competition in the pharmaceuticals market in Mexico, 2015

Figure 136: Drivers of buyer power in the pharmaceuticals market in Mexico, 2015

Figure 137: Drivers of supplier power in the pharmaceuticals market in Mexico, 2015

Figure 138: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2015

Figure 139: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2015

Figure 140: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2015

Figure 141: Netherlands pharmaceuticals market value: $ billion, 2011–15

Figure 142: Netherlands pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 143: Netherlands pharmaceuticals market share: % share, by value, 2015

Figure 144: Netherlands pharmaceuticals market value forecast: $ billion, 2015–20

Figure 145: Forces driving competition in the pharmaceuticals market in the Netherlands, 2015

Figure 146: Drivers of buyer power in the pharmaceuticals market in the Netherlands, 2015

Figure 147: Drivers of supplier power in the pharmaceuticals market in the Netherlands, 2015

Figure 148: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Netherlands, 2015

Figure 149: Factors influencing the threat of substitutes in the pharmaceuticals market in the Netherlands, 2015

Figure 150: Drivers of degree of rivalry in the pharmaceuticals market in the Netherlands, 2015

Figure 151: North America pharmaceuticals market value: $ billion, 2011–15

Figure 152: North America pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 153: North America pharmaceuticals market share: % share, by value, 2015

Figure 154: North America pharmaceuticals market value forecast: $ billion, 2015–20

Figure 155: Forces driving competition in the pharmaceuticals market in North America, 2015

Figure 156: Drivers of buyer power in the pharmaceuticals market in North America, 2015

Figure 157: Drivers of supplier power in the pharmaceuticals market in North America, 2015

Figure 158: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2015

Figure 159: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2015

Figure 160: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2015

Figure 161: Russia pharmaceuticals market value: $ billion, 2011–15

Figure 162: Russia pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 163: Russia pharmaceuticals market share: % share, by value, 2015

Figure 164: Russia pharmaceuticals market value forecast: $ billion, 2015–20

Figure 165: Forces driving competition in the pharmaceuticals market in Russia, 2015

Figure 166: Drivers of buyer power in the pharmaceuticals market in Russia, 2015

Figure 167: Drivers of supplier power in the pharmaceuticals market in Russia, 2015

Figure 168: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2015

Figure 169: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2015

Figure 170: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2015

Figure 171: Scandinavia pharmaceuticals market value: $ billion, 2011–15

Figure 172: Scandinavia pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 173: Scandinavia pharmaceuticals market share: % share, by value, 2015

Figure 174: Scandinavia pharmaceuticals market value forecast: $ billion, 2015–20

Figure 175: Forces driving competition in the pharmaceuticals market in Scandinavia, 2015

Figure 176: Drivers of buyer power in the pharmaceuticals market in Scandinavia, 2015

Figure 177: Drivers of supplier power in the pharmaceuticals market in Scandinavia, 2015

Figure 178: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Scandinavia, 2015

Figure 179: Factors influencing the threat of substitutes in the pharmaceuticals market in Scandinavia, 2015

Figure 180: Drivers of degree of rivalry in the pharmaceuticals market in Scandinavia, 2015

Figure 181: Singapore pharmaceuticals market value: $ billion, 2011–15

Figure 182: Singapore pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 183: Singapore pharmaceuticals market share: % share, by value, 2015

Figure 184: Singapore pharmaceuticals market value forecast: $ billion, 2015–20

Figure 185: Forces driving competition in the pharmaceuticals market in Singapore, 2015

Figure 186: Drivers of buyer power in the pharmaceuticals market in Singapore, 2015

Figure 187: Drivers of supplier power in the pharmaceuticals market in Singapore, 2015

Figure 188: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2015

Figure 189: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2015

Figure 190: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2015

Figure 191: South Africa pharmaceuticals market value: $ billion, 2011–15

Figure 192: South Africa pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 193: South Africa pharmaceuticals market share: % share, by value, 2015

Figure 194: South Africa pharmaceuticals market value forecast: $ billion, 2015–20

Figure 195: Forces driving competition in the pharmaceuticals market in South Africa, 2015

Figure 196: Drivers of buyer power in the pharmaceuticals market in South Africa, 2015

Figure 197: Drivers of supplier power in the pharmaceuticals market in South Africa, 2015

Figure 198: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2015

Figure 199: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2015

Figure 200: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2015

Figure 201: South Korea pharmaceuticals market value: $ billion, 2011–15

Figure 202: South Korea pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 203: South Korea pharmaceuticals market share: % share, by value, 2015

Figure 204: South Korea pharmaceuticals market value forecast: $ billion, 2015–20

Figure 205: Forces driving competition in the pharmaceuticals market in South Korea, 2015

Figure 206: Drivers of buyer power in the pharmaceuticals market in South Korea, 2015

Figure 207: Drivers of supplier power in the pharmaceuticals market in South Korea, 2015

Figure 208: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2015

Figure 209: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2015

Figure 210: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2015

Figure 211: Spain pharmaceuticals market value: $ billion, 2011–15

Figure 212: Spain pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 213: Spain pharmaceuticals market share: % share, by value, 2015

Figure 214: Spain pharmaceuticals market value forecast: $ billion, 2015–20

Figure 215: Forces driving competition in the pharmaceuticals market in Spain, 2015

Figure 216: Drivers of buyer power in the pharmaceuticals market in Spain, 2015

Figure 217: Drivers of supplier power in the pharmaceuticals market in Spain, 2015

Figure 218: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Spain, 2015

Figure 219: Factors influencing the threat of substitutes in the pharmaceuticals market in Spain, 2015

Figure 220: Drivers of degree of rivalry in the pharmaceuticals market in Spain, 2015

Figure 221: Turkey pharmaceuticals market value: $ billion, 2011–15

Figure 222: Turkey pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 223: Turkey pharmaceuticals market share: % share, by value, 2015

Figure 224: Turkey pharmaceuticals market value forecast: $ billion, 2015–20

Figure 225: Forces driving competition in the pharmaceuticals market in Turkey, 2015

Figure 226: Drivers of buyer power in the pharmaceuticals market in Turkey, 2015

Figure 227: Drivers of supplier power in the pharmaceuticals market in Turkey, 2015

Figure 228: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Turkey, 2015

Figure 229: Factors influencing the threat of substitutes in the pharmaceuticals market in Turkey, 2015

Figure 230: Drivers of degree of rivalry in the pharmaceuticals market in Turkey, 2015

Figure 231: United Kingdom pharmaceuticals market value: $ billion, 2011–15

Figure 232: United Kingdom pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 233: United Kingdom pharmaceuticals market share: % share, by value, 2015

Figure 234: United Kingdom pharmaceuticals market value forecast: $ billion, 2015–20

Figure 235: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2015

Figure 236: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2015

Figure 237: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2015

Figure 238: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2015

Figure 239: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2015

Figure 240: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2015

Figure 241: United States pharmaceuticals market value: $ billion, 2011–15

Figure 242: United States pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 243: United States pharmaceuticals market share: % share, by value, 2015

Figure 244: United States pharmaceuticals market value forecast: $ billion, 2015–20

Figure 245: Forces driving competition in the pharmaceuticals market in the United States, 2015

Figure 246: Drivers of buyer power in the pharmaceuticals market in the United States, 2015

Figure 247: Drivers of supplier power in the pharmaceuticals market in the United States, 2015

Figure 248: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2015

Figure 249: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2015

Figure 250: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2015

Figure 251: Johnson & Johnson: revenues & profitability

Figure 252: Johnson & Johnson: assets & liabilities

Figure 253: Novartis AG: revenues & profitability

Figure 254: Novartis AG: assets & liabilities

Figure 255: Pfizer Inc.: revenues & profitability

Figure 256: Pfizer Inc.: assets & liabilities

Figure 257: F. Hoffmann-La Roche Ltd: revenues & profitability

Figure 258: F. Hoffmann-La Roche Ltd: assets & liabilities

Figure 259: Daiichi Sankyo Co., Ltd.: revenues & profitability

Figure 260: Daiichi Sankyo Co., Ltd.: assets & liabilities

Figure 261: Dr. Reddy's Laboratories Limited: revenues & profitability

Figure 262: Dr. Reddy's Laboratories Limited: assets & liabilities

Figure 263: Sanofi SA: revenues & profitability

Figure 264: Sanofi SA: assets & liabilities

Figure 265: AstraZeneca PLC: revenues & profitability

Figure 266: AstraZeneca PLC: assets & liabilities

Figure 267: Bayer AG: revenues & profitability

Figure 268: Bayer AG: assets & liabilities

Figure 269: Boehringer Ingelheim GmbH: revenues & profitability

Figure 270: Boehringer Ingelheim GmbH: assets & liabilities

Figure 271: GlaxoSmithKline Plc: revenues & profitability

Figure 272: GlaxoSmithKline Plc: assets & liabilities

Figure 273: Aspen Pharmacare Holdings Ltd: revenues & profitability

Figure 274: Aspen Pharmacare Holdings Ltd: assets & liabilities

Figure 275: Merck & Co., Inc.: revenues & profitability

Figure 276: Merck & Co., Inc.: assets & liabilities

Figure 277: Yunnan Baiyao Group Co., Ltd.: revenues & profitability

Figure 278: Yunnan Baiyao Group Co., Ltd.: assets & liabilities

Figure 279: Aurobindo Pharma Limited: revenues & profitability

Figure 280: Aurobindo Pharma Limited: assets & liabilities

Figure 281: Lupin Limited: revenues & profitability

Figure 282: Lupin Limited: assets & liabilities

Figure 283: Sun Pharmaceutical Industries Ltd.: revenues & profitability

Figure 284: Sun Pharmaceutical Industries Ltd.: assets & liabilities

Figure 285: PT Kalbe Farma Tbk: revenues & profitability

Figure 286: PT Kalbe Farma Tbk: assets & liabilities

Figure 287: Astellas Pharma GmbH: revenues & profitability

Figure 288: Astellas Pharma GmbH: assets & liabilities

Figure 289: Takeda Pharmaceutical Company Limited: revenues & profitability

Figure 290: Takeda Pharmaceutical Company Limited: assets & liabilities

Figure 291: Adcock Ingram Holdings Limited: revenues & profitability

Figure 292: Adcock Ingram Holdings Limited: assets & liabilities

Figure 293: Daewoong Pharmaceutical Co., Ltd.: revenues & profitability

Figure 294: Daewoong Pharmaceutical Co., Ltd.: assets & liabilities

Figure 295: Almirall S.A.: revenues & profitability

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports